Terms: = Colorectal cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534
18 results:
1. Mental Health Morbidities and Time to cancer Diagnosis Among Adults With Colon cancer in England.
Benitez Majano S; Lyratzopoulos G; de Wit NJ; White B; Rachet B; Helsper C; Usher-Smith J; Renzi C
JAMA Netw Open; 2022 Oct; 5(10):e2238569. PubMed ID: 36315146
[TBL] [Abstract] [Full Text] [Related]
2. etv1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in colorectal cancer.
Shen X; Zhou C; Feng H; Li J; Xia T; Cheng X; Zhao R; Zou D
Front Immunol; 2022; 13():939806. PubMed ID: 35860243
[TBL] [Abstract] [Full Text] [Related]
3. Disparities in quality of life, social distress and employment outcomes in Australian cancer survivors.
White VM; Lisy K; Ward A; Ristevski E; Clode M; Webber K; Emery J; Ijzerman MJ; Afshar N; Millar J; Gibbs P; Evans S; Jefford M
Support Care Cancer; 2022 Jun; 30(6):5299-5309. PubMed ID: 35279769
[TBL] [Abstract] [Full Text] [Related]
4. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study.
Żok J; Bieńkowski M; Radecka B; Korniluk J; Adamowicz K; Duchnowska R
BMC Cancer; 2021 May; 21(1):529. PubMed ID: 33971834
[TBL] [Abstract] [Full Text] [Related]
5. Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of etv1 and MAPK Pathway in colorectal cancer.
Batzorig U; Wei PL; Wang W; Huang CY; Chang YJ
Int J Med Sci; 2021; 18(11):2251-2261. PubMed ID: 33967600
[TBL] [Abstract] [Full Text] [Related]
6. Cooperation between ETS transcription factor etv1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract] [Full Text] [Related]
7. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
[No Abstract] [Full Text] [Related]
8. Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer.
Orlando G; Law PJ; Cornish AJ; Dobbins SE; Chubb D; Broderick P; Litchfield K; Hariri F; Pastinen T; Osborne CS; Taipale J; Houlston RS
Nat Genet; 2018 Oct; 50(10):1375-1380. PubMed ID: 30224643
[TBL] [Abstract] [Full Text] [Related]
9. Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome.
Paudel MS; Mandal AK; Shrestha B; Poudyal NS; Kc S; Chaudhary S; Shrestha R; Goel K
JNMA J Nepal Med Assoc; 2018; 56(209):487-492. PubMed ID: 30058630
[TBL] [Abstract] [Full Text] [Related]
10. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract] [Full Text] [Related]
11. Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
Housseau F; Wu S; Wick EC; Fan H; Wu X; Llosa NJ; Smith KN; Tam A; Ganguly S; Wanyiri JW; Iyadorai T; Malik AA; Roslani AC; Vadivelu JS; Van Meerbeke S; Huso DL; Pardoll DM; Sears CL
Cancer Res; 2016 Apr; 76(8):2115-24. PubMed ID: 26880802
[TBL] [Abstract] [Full Text] [Related]
12. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract] [Full Text] [Related]
13. Analyses of 7,635 Patients with colorectal cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
[TBL] [Abstract] [Full Text] [Related]
14. Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer.
Al Khaldi RM; Al Mulla F; Al Awadhi S; Kapila K; Mojiminiyi OA
Dis Markers; 2011; 30(4):197-212. PubMed ID: 21694446
[TBL] [Abstract] [Full Text] [Related]
15. Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients.
Vrdoljak E; Omrcen T; Boban M; Hrepic D
J BUON; 2008; 13(4):513-8. PubMed ID: 19145672
[TBL] [Abstract] [Full Text] [Related]
16. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract] [Full Text] [Related]
17. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract] [Full Text] [Related]
18. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM
Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322
[TBL] [Abstract] [Full Text] [Related]
